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Blood Flow to Infarct and Surviving Myocardium: Implications
Regarding the Action of Verapamil on the Acutely Ischemic Dog Heart
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STEPHEN E. EPSTEIN, MD, FACC
Bethesda, Maryland
After coronary occlusion, myocardium originally sup-
plied by the occluded vessel ultimately separates into
ipfarct and surviving muscle. To clarify this process,
evolution of collateral b!ood flow to infarct and to sur-
viving mYQcardium was retrospectively analyzed after
permanent left anterior descending occlusion in 24 closed
chest dogs. Microspheres were injected before occlusion
and 5 and 20 minutes and 4 hours after occlusion. Ten
minutes after occlusion, dogs received either verapamil,
0.4 mg/kg, followed by 0.6 mg/kg per hour for 6 hours
(n = 10) or equivalent saline solution (n = 14). These
dogs were sacrificed 3 days later, the distribution of the
occluded artery was defined by dye perfusion and in-
farcted myocardium was determined by triphenyltetra-
zolium staining of heart slices. Surviving muscle within
the distribution of the occluded artery was divided into
medial regions adjacent to the infarct (medial adjacent)
and remote from the infarct (medial remote) and lateral
regions adjacent to infarct (lateral adjacent) and remote
Complete coronary artery occlusion ultimately results in
survival of a variable amount of myocardium previously
supplied by the occluded artery. The amount of surviving
muscle has generally been thought to depend on the extent
of local perfusion supplied by collateral channels. Jugdutt
et al. (1,2) demonstrated consistent survival of canine myo-
cardium at blood flow above 40 mllmin per 100 g soon after
occlusion. However, a variety of circumstances may affect
minimal coronary flow values compatible with tissue sur-
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from the infarct (lateral remote). In both control and
verapamil groups, collateral flows in all regions in-
creased significantly by 140 to 400% over 4 hours. How-
ever, the relative magnitude ofcollateral flow to different
regions showed a consistent order: infarct < medial ad-
jacent < medial remote < lateral remote. There were
no significant differences in regionally matched flows or
size of infarction between control and verapamil-treated
groups.
Collateral perfusion begins to show distinctive pat-
terns of change in infarct and surviving muscle very soon
after coronary occlusion. Collateral flow within subdi-
visions of the occluded coronary artery bed increases as
distance from the infarct increases, with lateral segments
having higher flows than medial segments. This relation
persists during the first 4 hours after occlusion. In this
study, verapamil neither increased collateral flow to the
occluded bed nor altered minimal flow requirements for
myocardial survival.
vival. For example, interventions that alter the metabolic
demands of threatened myocardium may produce corre-
sponding changes in flow requirements, thereby influencing
local tissue survival. Ibuprofen (2-[4-isobutylphenyl]-pro-
pionic acid) decreases the size of infarction without altering
either coronary collateral blood flow or determinants of
myocardial metabolic rate, presumably by attenuating early
inflammatory responses (3,4). Thus, an intervention meant
to salvage myocardium might operate through increasing
collateral blood flow to the ischemic tissue or by decreasing
the vulnerability of the threatened area by any of several
mechanisms until natural expansion and proliferation of col-
lateral vessels provide sufficient flow to sustain the jeop-
ardized tissue. Local myocardial salvage or necrosis might
also be markedly influenced by the location of the tissue
within the region at risk (that is, the region normally sup-
plied by the occluded artery) if there is an inhomogeneity
of local flow within this region.
The mechanism of promising pharmacologic agents must
be evaluated to foster new approaches promoting myocardial
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survival after coronary occlusion. In this study, we devel-
oped a model to investigate flow differentials within the
region at risk and relate such flows to ultimate infarction or
survival. The model sought to differentiate between en-
hanced tissue survival due to improved collateral blood flow
and tissue salvage secondary to diminished metabolic needs
or altered inflammatory response. The position of myocar-
dium at risk relative to infarcting tissue and the time after
coronary occlusion were examined as these variables related
to both flow and survivaL We applied our model to evaluate
the mechanism of action of a relevant pharmacologic in-
tervention by administering the calcium channel blocker,
verapamil, after coronary occlusion. Verapamil has been
found to diminish tissue necrosis (4,5) and mitochondrial
damage (6) in ischemic myocardium.
Methods
Experimental preparation and protocol. Under gen-
eral anesthesia (nitrous oxide and halothane) and sterile
conditions, 24 foxhounds, weighing 21 to 29 kg, were fitted
with a hydraulic cuff around the left anterior descending
coronary artery immediately beyond the first diagonal branch.
A tube permitting cuff inflation, a left atrial catheter and
left atrial recording wire were brought out of the thorax to
a subcutaneous pouch. The sealed distal end of a femoral
artery catheter was also placed in a subcutaneous pouch.
After surgery, all animals received intramuscular benzathine
penicillin, 22,000 U/kg body weight, and procaine penicillin
22,000 U/kg daily, I day before, the day of and 2 days after
surgery. Six to 8 days after surgery, under morphine (I
mg/kg) and light pentobarbital (8 to 10 mg/kg) sedation.
the catheter ends were exteriorized from the subcutaneous
pouch. After the catheters were determined to be functional
and the hemodynamic status stable, I million radioactively
labeled microspheres (15 ± 5 fL; 3M Co.) were injected
through the left atrial catheter 15 seconds after initiating a
steady withdrawal of blood from the femoral artery, as de-
scribed previously (7,8). After blood collection. the left
anterior descending artery was occluded by inflation of the
hydraulic cuff with saline solution. Blood flow measurement
using the microsphere technique was made 5 minutes after
the occlusion.
Administration ofverapamil or saline solution. After the
5 minute blood flow measurement, 10 dogs were chosen by
random selection process to receive an intravenous bolus of
verapamil, 0.4 mg/kg, followed by a continuous verapamil
infusion at 0.6 mg/kg per hour for 6 hours after the occlu-
sion. Verapamil was dissolved in normal saline solution at
a concentration of 0.0525 mg/kg per ml and passed through
a millipore filter for sterilization. Microspheres with dif-
ferent radionuclide labels were injected for blood flow mea-
surements 20 minutes after occlusion (10 minutes after ini-
tiation of saline or verapamil infusion) and 4 hours after the
coronary occlusion. The 14 remaining animals received sa-
line solution. Hemodynamic measurements were recorded
every 30 minutes during the course of the infusion. After
the last microsphere injection, the catheter ends were sealed
and returned to the subcutaneous pouch. The infusion of
verapamil continued for 2 hours after the last microsphere
blood flow measurement.
Postmortem studies. Staining and cutting the excised
hearts. Three days after coronary occlusion, each animal
was given heparin and a lethal dose of sodium pentobarbital.
The heart was removed and the cuff checked for full inflation
and complete arterial occlusion. The coronary artery distal
to the occlusion was perfused with Evans blue dye (1.0%)
in 6% dextran in normal saline solution and the aorta was
simultaneously perfused with fluorescein (0. 1%) in 6% dex-
tran in normal saline solution at identical physiologic pres-
sures (8,9). Simultaneous perfusion at identical pressures
prevented flow between the vascular bed of the region at
risk and the remainder of the left ventricle. With this tech-
nique, the region normally supplied by the occluded artery
(the anatomic region at risk of infarction) is stained blue.
while the rest of the heart is colored fluorescent yellow-
green. The atria and right ventricle were removed and the
left ventricle cut into 10 slices parallel to the atrioventricular
groove. After the entire left ventricle was weighed, slices
were divided into the blue stained region at risk and the
fluorescein-stained normal region. Alternate slices were in-
cubated in triphenyltetrazolium-chloride as previously de-
scribed (8,9). Within the region at risk, the infarct zone was
identified as pale (tetrazolium negative) and surviving mus-
cle as bright red (tetrazolium positive) (10). The entire in-
farct zone was dissected from the risk region and bottled
for gamma counting.
The noninfarcted area of the risk region was divided into
six sections (Fig. 1). The epicardial layer overlying the
infarct was cut into inner and outer halves, designated as
medial adjacent (adjacent to the infarct) or medial remote
(remote from the infarct). The two lateral portions of the
surviving tissue were halved similarly into lateral adjacent
(primarily endocardial) and lateral remote regions. All tissue
from a given subdivision (for example, infarct or medial
adjacent) of the region at risk was pooled except for an
apical "cap" that was divided into infarct and surviving
portions and counted separately. Samples from the normal
zone of apical and basal slices were divided into epicardial
and endocardial halves for counting. All tissue samples were
weighed, and the total weight of infarct and the total weight
of the region at risk were calculated.
For the initial 19 animals in the experiment (12 control
and 7 verapamil-treatedj. alternate heart slices were incu-
bated in triphenyltetrazolium-chloride before the designa-
tion of infarct, medial adjacent and so forth, was made. The
remaining slices from these 19 hearts were subdivided with
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Figure 1. Differentiation of both the normal zone (fluorescein
stained) and risk region (Evans blue stain) within each' 'breadloaf'
heart slice. Area of infarction was delineated by triphenyltetra-
zolium-chloride stain; subdivisions of the risk region were sub-
sequently determined by relation to infarcted tissue. RV = right
ventricle.
the only staining due to differential dye perfusion. In these
slices, gross appearance (pallor) and firmness were used to
identify the infarcted tissue. The tetrazolium-staining pro-
cedures did not leach microspheres, as determined by the
comparison of the normal zone preocclusion flows. In the
final five experiments, all slices were stained with triphen-
yltetrazolium because the flow calculation was not jeopard-
ized by the staining procedure.
/n one dog with no detectable infarct and a second with
a 0.06 g infarct. the region at risk was split into endocardial
and epicardial halves. The medial third of the endocardial
half was considered the medial adjacent region and the lat-
eral thirds, the lateral adjacent region. The epicardial half
of the region at risk was split into portions designated medial
remote (medial third) and lateral remote (lateral thirds).
/n a separate series of /0 dogs treated in a manner
identical to control dogs. samples from infarct and medial
adjacent regions were stained with hematoxylin-eosin. The
percent of necrotic tissue in each "infarct" sample and in
each "medial adjacent" sample was determined by projec-
tion of slides with histologic sections onto graph paper.
Tissue was counted for radioactivity and flows were cal-
culated by standard techniques reported previously (II).
Statistical methods. Statistical methods included com-
parison of means by the Student's unpaired t test with prob-
ability [p J less than 0.05 taken as significant; changes over
time were also analyzed by the Student's paired (test. Anal-
ysis of homogeneity of distribution was done with a chi-
square test (12). The significance of correlation coefficients
was obtained from a table of critical values (12). All results
are expressed as mean ± standard error of the mean. Stan-
dard deviations and ranges are also given to characterize
the spread of individual observations.
Results
Hemodynamics. No significant change in heart rate or
blood pressure occurred during the experiment in the control
animals, although a modest tendency to increase heart rate
was noted 20 minutes after occlusion (Table I). In the ver-
apamil-treated dogs, heart rate increased significantly 20
minutes after occlusion (10 minutes after administration of
the drug bolus) and remained significantly higher than heart
rate in the control dogs 30 minutes after occlusion. The
heart rate of the verapamil-treated dogs tended to remain
slightly higher throughout the remainder of experiment, al-
though this tendency did not achieve statistical significance
after 30 minutes. Verapamil-treated dogs did not experience
any consistent change in blood pressure.
Separation of tissue. The accuracy of dividing tissue
on the basis of tetrazolium-staining characteristics was de-
termined by microscopic examination of samples of each
designated tissue. "Infarct" by tetrazolium staining was
98.2% necrotic with 1.8% surviving tissue. In several sam-
ples of infarct, the endocardial and epicardial aspects of
tissue sample were examined separately: endocardial portion
was 99.5% necrotic tissue and epicardial portion was 97%
necrotic.
Tissue designated as medial adjacent by its immediate
proximity to the tetrazolium-identified infarct was found to
contain 11.7% necrotic tissue, with 88.3% surviving tissue.
These measurements indicate that the maximal flow dis-
crepancy due to tissue admixture is 12% of observed values.
Microsphere flow values. Microspheres are distributed
uniformly to each nonischemic myocardial layer. Thus, de-
creased content of microspheres injected before occlusion
is interpreted as a consequence of the ischemic event (7, II , 13).
Preocclusion flow values indicated a 38% mean decrease in
preocclusion microsphere content throughout the area at risk
in both the control and verapamil-treated dogs (Fig. 2).
However, the decrease of microsphere content was similar
throughout the region at risk in both infarcted and surviving
tissue. Thus, comparisons among tissues within the region
at risk were not affected by microsphere loss. In agreement
with previous findings (14), our results suggest that an isch-
emic insult need not progress to frank infarction before
alteration in microsphere content is observed.
Time course of blood flow measurements (Table 2,
Fig. 3). Normal zone flow in control dogs remained rela-
tively constant throughout the experiment. In verapamil-
treated dogs, however, the normal zone flow increased 86%
in the endocardium and 185% in the epicardium (versus in
control dogs, p < 0.05) 10 minutes after beginning vera-
pamil and 20 minutes after occlusion. Although the vera-
pamil-treated dogs continued to have higher normal zone
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Table 1. Hemodynamics in 14 Control (saline-treated) and 10 Verapamil-Treated Dogs
Time After OcclusionPre-
occlusion 5 min 20 min 30 min I h 2h 3 h 4h 6h
Heart rate
(beats/min)
Saline 87 ± 7 86 ± 6 100 ± 7 83 ± 8 92 ± 7 77 ± 6 73 ± 7 79 ± 8
Verapamil 73 ± 6 92 ± 6 131 ± 5* 132 ± 6* 112 ± 6 105 ± 4 103 ± 7 90 ± 6 94 ± 7
Arterial blood
pressure (mm Hg)
Saline 86 ± 3 85 ± 3 85 ± 7 94 ± 4 93 ± 2. 91 ± 3 87 ± 3 86 ± 3
Verapamil 88 ± 2 92 ± 4 89 ± 5 95 ± 5 86 ± 5 81 ± 4 82 ± 5 78 ± 4 77 ± 4
*p < 0.05 vs. control dogs. Values presented are mean ± standard error of the mean.
flows 4 hours after occlusion compared with that in the
control dogs, the differences from control were not significant.
At 5 minutes after occlusion, the tissue that ultimately
became infarcted in either treatment group had a signifi-
cantly (p < 0.05) lower flow than any other area in the risk
region. Although the infarcted area in the control dogs showed
significant increases 20 minutes and 4 hours after occlusion,
it remained the area of lowest flow (Fig. 3). Verapamil-
treated dogs tended to have smaller increase in flow to the
infarcted area at 4 hours. Twenty minutes after occlusion.
surviving areas of the region at risk remote from the infarct
had a significant increase in flow in control dogs. This
increase in flow was seen 20 minutes after occlusion in the
lateral remote (but not medial remote) region in the vera-
pamii-treated dogs. Four hours after the occlusion, all areas
within the region at risk in the control group had an increase
Figure 2. Preocclusion flow values, in ml/min per lOa g (assessed
by persistence of microsphere content), 3 days after occlusion in
14 control and 10 verapamil-treated dogs. 1 = infarct; LA =
lateral adjacent; LR = lateral remote; MA = medial adjacent;
MR == medial remote; NZ ENDO = normal zone endocardium;
NZ EPI = normal zone epicardium.
Mean Preocclusion Flow ml/minl100g
- (n= 24)
in flow, with remote regions having the greatest flows and
the infarct having the lowest flow. Verapamil-treated dogs
behaved similarly.
In summary. the most significant effect of verapamil
treatment on regional blood flow was a marked increase in
flow in normal nonischemic myocardium. Flows within the
region at risk were not different between the control and
verapamil-treated animals.
Relation of blood flow values to ultimate survival or
necrosis (Fig. 4 A to C). This was examined by calculating
the percent of infarct samples (one value per animal) in
graded flow intervals. Similar percents were determined for
surviving tissue in the risk region. Flow distribution 5 min-
utes after the occlusion (Fig. 4A) showed that 62% of the
ischemic samples that progressed to infarct in control dogs
had a 5 minute blood flow of less than I mIlmin per 100
g. Interestingly, 21 % of the medial adjacent samples (that
is, surviving myocardium) in the control dogs also had a
very early flow of less than I mllmin per 100 g. All tissue
with a 5 minute flow of more than 10 mllmin per 100 g
survived in both the control and verapamil-treated groups.
In distribution profile, an intervention that preserved isch-
emic myocardium by any mechanism (for example, aug-
mentation of collateral blood flow, suppression of metabolic
activity or interference with inflammatory processes) would
be manifest by an increase in the number of salvaged tissue
samples in the low flow categories. In this experiment, a
chi-square distribution test showed no significant difference
between control and verapamil-treated groups.
Twenty minutes after occlusion, all infarcting samples
in both control and verapamil-treated groups (Fig. 4B) had
a flow less than 10 mllmin per 100 g. However, some
surviving samples, particularly medial adjacent samples,
also had very low flows. The distribution of the infarct
samples and the distribution of the medial adjacent samples
were not different as determined by a chi-square analysis
between treated and control groups. Figure 48 suggests that
the verapamil-treated group had greater survival (40 versus
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Table 2. Myocardial Blood Flow (mllmin per 100 g)
Time
After
Occlusion
5 min
20 min
4 h
5 min
20 min
4h
Region at Risk
Medial Lateral Medial Lateral Normal Normal
Infarct Adjacent Adjacent Remote Remote Endocardium Epicardium
A. 14 Control (saline-treated) Dogs
2.2* 8.5 22.0 19.3 27.2 89.1 92.7
±0.93 ± 2.6 ± 5.3 ± 4.4 ± 4.8 ± 8.1 ± 10.0
4.3*7 13.2 24.1 33.8';' 45.17 113.9 104.1
±0.93 ± 2.5 ± 3.7 ± 5.1 ± 7.3 ± 10.4 ± 10.6
8.8*t 24.0t 33. ]'f 47.87 56.9t 107.1 100.3
±3.1 ± 5.1 ± 6.1 ± 1.9 ± 12.5 25.2 ± 16.1
B. 10 Verapamil-Treated Dogs
2.3* 6.7 19.7 20.0 36.2 110.9 89.6
±1.2 ± 2.4 ± 4.9 ± 4.2 ± 6.1 ± 10.2 ± 7.3
2.0* 8.6 30.9 27.3 66.07 206.77:j: 255.47:j:
±0.64 ± 2.3 ± 9.5 ± 6.6 ± 13.0 ± 31.9 ± 41.6
6.9* 18.77 3l.3t 36.5i' 51.07 112.47 127.0t
±4.1 ± 4.2 ± 4.5 ± 6.3 ± 5.2 ± 14.7 ± 17.8
*p < 0.05 versus all noninfarcted categories at same time period; tp < 0.05 from previous measurement in same region; :j:p < 0.05 versus control
in same region at same time period. Values presented are mean ± standard error of the mean.
14% of medial adjacent samples in control hearts) in the I
to 5 mllmin per 100 g category, but this difference was not
statistically significant. As occurred at 5 minutes after oc-
clusion, all tissue with a flow of more than 10 mllmin per
100 g survived.
Even at 4 hours after occlusion, infarcting and surviving
tissues do not have entirely distinct flow values; some over-
lap does persist. Although the flows retain the characteristic
ranking of: infarct < medial adjacent < lateral adjacent <
medial remote < lateral remote samples, certain tissues
survive at low flows whereas other tissues do not (Fig. 4C).
One factor that may account for the difference in viability
at low flows is heart rate. An analysis of heart rate versus
the flows in the medial adjacent region 20 minutes after
occlusion is shown in Figure 5. The absence of any cor-
relation in either the control or verapamil-treated group, or
both groups taken together, suggests that heart rate did not
playa clearly decisive role in viability for a given level of
blood flow. The 20 minute time period was chosen for heart
rate analysis because, at this time, heart rate was maximally
different between the two groups.
Infarct size. Infarct size was determined by weight. The
extent of the risk region was determined by the summed
weights of infarct, medial adjacent, lateral adjacent, medial
remote and lateral remote samples. In the control dogs, the
mean infarct size was 23.9% of the risk region (range 0 to
40.9%), with a mean weight of 5.9 ± 1.1 g (standard
deviation ± 4.0 g). The risk region weighed 26.1 ± 3.3
g (standard deviation ± 12.5 g), averaging 26.7% of the
left ventricle (range 12.5 to 61.7%). In the verapamil-treated
group, the infarct as percent of risk region averaged 28.5%
(10.3 ± 3.0 g; standard deviation ± 9.5 g) (range 0.07 to
68.4%), with an average risk region of 30.0% (32.9 ± 2.8
g; standard deviation ± 8.9 g) of the left ventricle (range
22.8 to 34.5%). The mean left ventricular weight for the
control group was 100.2 ± 3.0 g (standard deviation ±
11.1 g) and for the verapamil-treated group, 114.2 ::t 6.5
g (standard deviation ± 20.7 g). The percent of area at risk
infarcting, the percent of left ventricle at risk and the ab-
solute weight of infarct, risk region and left ventricle were
not significantly different between the two groups.
Discussion
Methodologic considerations. The method presented in
this study is designed to give information about both the
location and extent of myocardial salvage and about the
possible mechanism of salvage. In our method, local infarct
sparing due to any mechanism would be characterized by
early flow values in surviving myocardium of verapamil-
treated dogs that are lower than the lowest values in sur-
viving muscle of control dogs (Table 3A). For example,
infarct sparing might produce lower average flows in the
medial adjacent or lateral adjacent subdivisions of the region
at risk. In this manner, our method offers a means to localize
and quantitate salvaged myocardium within a larger region
at risk, not all of which is rendered severely ischemic by
coronary occlusion.
Information concerning mechanism comes from an anal-
ysis of the evolution of collateral blood flow (Table 3B. C).
Infarct sparing could result from survival at a lower rate of
lACC Vol. 3. NO.4
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blood flow (for example, due to reduced metabolic rate) or
an increase in collateral blood flow. Myocardial salvage due
to mechanisms unrelated to improvement in collateral blood
flow (reduced myocardial metabolism or possibly retarda-
tion of inflammatory processes or some other mechanism
lowering flow requirements for survival) should lower both
pretreatment and post-treatment flow values in surviving
myocardium below the minimum for survival seen in control
dogs. Lower mean flow values would also be observed in
the infarcted region. Some poorly perfused myocardium
would survive as a result of treatment, and only the most
severe flow deprivation would cause myocardium to infarct
after treatment.
Increases in collateral blood flow responsible for en-
hanced myocardial survival would be revealed by a paired
comparison of pretreatment and post-treatment measure-
ments (Table 3C). Myocardial salvage due to improved local
collateral blood flow can be inferred if: I) pretreatment flow
in surviving myocardium of treated dogs is below the min-
imal level associated with local myocardial survival in con-
trol dogs, and 2) post-treatment flow in treated dogs is at
or above that level. If myocardium is salvaged by improved
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Figure 4. Flow distribution as percent of samples (one sam-
ple/region per each dog) in control and verapamil-treated dogs 5
minutes (A), 20 minutes (B) and 4 hours (C) after coronary oc-
clusion. Blood flow ranges, in mllmin per 100 g, are given on the
horizontal axes. Flow values coinciding with a division point be-
tween two ranges were classified in the higher range.
collateral blood flow, verapamil-treated dogs would have
lower pretreatment flows, but post-treatment flow values for
surviving and infarcted tissue would be the same in both
treated and untreated dogs.
It is possible that a single intervention would both de-
crease myocardial metabolic rate and improve collateral
blood flow. In this case, the minimal flow necessary for
survival would decrease; this would be seen as a lower flow
in the infarcted tissues of treated as compared with control
dogs. Adjacent salvaged areas would have mean flow values
lower than those of control dogs before and after treatment
and a greater increase in flow after treatment. Thus, with
both decreased threshold for survival and increased collat-
eral flow, salvaged tissue would show values midway be-
tween values expected for either mechanism alone.
Relation of blood flow and tissue survival. Studies
applying the foregoing analysis reveal general patterns of
flow evolution in surviving and necrotic tissue. Myocardium
destined to infarct had extremely low flows during the first
4 hours after occlusion. Some medial adjacent samples from
some dogs survived with very low flows, while infarcts
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Figure 5. Blood flow, in ml/min per 100 g, in the medial adjacent
region 20 minutes after coronary occlusion plot&d against simul-
taneously measured heart rate (beats/min).
occurred in other dogs at the same or higher flows. None-
theless, within a given heart, infarct flow was always lower
than medial adjacent flow and showed less absolute increase
in flow. These circumstances suggest that factors other than
flow, and perhaps other than metabolic rate, may influence
the fate of ischemic myocardium. In this situation, no single
flow value is likely to give an absolutely reliable prediction
of survival or nonsurvival. The rapid increase of flow in
most surviving tissue suggests that the length of time in
which flow is low is important. It should be emphasized
that flow in all subdivisions of the region at risk (inclucting
the infarct) increased over time, but the absolute magnitude
of the rise increased as the distance from the infarct in-
creased. However. in three control and two verapamil-treated
animals, medial adjacent flows were below 10 ml/min per
100 g 4 hours after occlusion. In these dogs. no identifiable
hemodynamic factors were associated with the ultimate sur-
vival of tissue with very low flows.
In contrast, there appear to be distinct regions within
remote areas, where flow, although diminished, remains
greater than 50% of normal zone flow. It seems unlikely
that this tissue would infarct except under circumstances of
extremely high metabolic demands. Thus, our data support
the concept that myocardium with flow over 40 ml/min per
100 g will survive under most circumstances (1,2). How-
ever, our findings also indicate that regions of myocardium
frequently survive despite local flow rates well below 40
ml/min per 100 g. This may reflect relatively low myocardial
metabolic rates in our closed chest model.
Within the surviving portion of the risk region, flow is
nonuniform. The tissues remote from the infarct, both me-
dially and laterally, are better perfused than portions of the
risk region adjacent to the infarct. The remote regions ex-
perience an increase in flow within the first 20 minutes after
occlusion at a time when an increase in flow is not seen in
the adjacent zones. Thus, the increase in flow starts at the
periphery of the region at risk, and the location of the tissue
within the risk region is a major determinent of its chance
for survival. This change in flow after occlusion may be a
specific characteristic of animals with good collateralization,
as Geary et al. (15) found numerous epicardial collateral
vessels and a regional decrease in ST segment elevation
over time in dogs but not in pigs or baboons.
Table 3. Analysis of Regional Blood Flow Data
Treated Dogs Control Dogs
A. Infarct sparing F(S) < Min F(S)
FO) < Fm
Infarct extension Min I'(S) or FO) > Min F(S)
FO) > F(I)
B. Infarct sparing unrelated to F
5 min (pretreatment) F(S) < Min F(S)
20 min (post-treatment) PiS) < Min F(S)
Infarct extension unrelated to F
5 min (pretreatment) Min F(S) or Fm > Min F(S)
20 min (post-treatment) Min PiS) or Fm > Min F(S)
C. Infarct sparing due to i F
5 min (pretreatment) F(S) < Min F(S)
20 min (post-treatment) F(S) > Min F(S)
Infarct extension due to t F
5 min (pretreatment) Min FrS) or FO) > Min F(S)
20 min (post-treatment) Min F(S) or FO) < Min F(S)
F = local myocardial blood now within region specified by symbol in parentheses: I infarcting myo-
cardium: Min = minimal now value observed in any surviving region: S = surviving myocardium. t =
decreased; i = increased. Times cited arc times after coronary occlusion; treatment is started 10 minutes
after occlusion. When time is not cited (Category A). pretreatment status is implied.
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Lateral portions of the risk region, both remote and ad-
jacent. are better perfused than medial portions. This find-
ing may be an artifact created by the inclusion of a small
interdigitating portion of tissue (about 15% of sample weight)
from normally perfused regions. This percent is in close
agreement with the amount of normally perfused myocar-
dium in the border zones found by Patterson and Kirk (16)
with a microsphere-Iabeling technique that identified sources
of local perfusion in dog hearts with coronary occlusion.
Infarct size. Infarct size varied substantially in both con-
trol and verapamil-treated preparations. In part, this re-
flected natural variability in size of the risk region as de-
termined by the anatomy of the distal left anterior descending
coronary artery. However, the extent of infarction still ranged
from 0 to 41 % within individual risk regions. Our studies
indicate that much, but not all, variability in extent of in-
farction within risk regions Can be attributed to differences
in local myocardial perfusion. Such differences are likely a
result of variation in number and size of interarterial an-
astamoses and inhomogeneity of collateral blood flow dis-
tribution within a given risk region, probably caused by
transmural gradations of intramyocardial pressure. Discrep-
ancies in metabolic activity might also be expected to cause
corresponding differences in extent of infarction. Never-
theless, heart rate, a major determinant of myocardial met-
abolic activity, did not exert great influence on infarct size
independent of collateral blood flow. This is seen in the
lack of consistent effect of heart rate on minimal blood flow
to surviving myocardium (Fig. 5).
Microsphere content. In this study, the content of mi-
crospheres injected before occlusion is uniformly decreased
within the risk region. The equivalent loss in both infarcting
and surviving myocardium suggests that it is not the in-
farction process itself that produced the loss, but rather a
phenomenon associated with decreased blood flow. This is
consistent with our previous studies (14) showing micros-
phere loss in ischemic endocardium as early as 4 hours after
coronary occlusion.
The possibility of improving accuracy ofbloodflow mea-
surements by using a correction factor has been the focus
ofmuch controversy. Correction factors based on the percent
loss of preocclusion microspheres assume that the circum-
stances of loss of postocclusion microspheres parallel
those of loss of preocclusion microspheres. In this study,
the consistency of microsphere loss within the region at risk
allowed accurate comparison between subdivisions of the
risk region without utilizing correction factors. In addition,
the blood flows in one region at different times can be
considered without correction. However, comparison of flows
in the region at risk with flows in normal regions or the
interpretation of absolute flows within the ischemic area
might lead to erroneous conclusions. Murdock and Cobb
(7) argued that the decrease in microsphere content in the
ischemic region caused only very small changes in calcu-
lated flow and thus was not a significant source of error.
However, small but significant absolute flow changes in both
markedly and moderately ischemic myocardium have been
of considerable scientific interest because they may repre-
sent large relative changes. Blood flow changes over time
and comparisons within subdivisions of the ischemic region
appear to be the most reliable methods of assessing the
effects of interventions.
Effects of verapamil. The dose of verapamil used in
this study was clearly sufficient to increase normal zone
flow, probably by means other than increasing heart rate
(Fig. 5). However, verapamil did not increase collateral
blood flow significantly to any subdivision of the region at
risk. The trend toward increased flow to the lateral remote
regions after verapamil is consistent with an admixture of
15% normal tissue. If verapamil did produce a selective
increase in collateral flow to the lateral portions ofthe region
at risk, such flow increase would only affect subdivisions
with little likelihood of necrosis even in the absence of
intervention. Other laboratories have reported (17-19) that
verapamil does not increase collateral flow in dog models
of acute myocardial infarction. Dose levels of verapamil
other than the one used in this study do not appear to induce
increases in collateral flow in acute ischemia (20).
Verapamil might exert an infarct-sparing influence un-
related to collateral blood flow due to a decrease in meta-
bolic rate or calcium accumulation in ischemic myocardium
(6). This influence would decrease the minimal local blood
flow necessary for tissue survival. In our studies, mean flows
to infarcting tissue and surviving myocardium at greatest
jeopardy (mediai adjacent region) were virtually identical
in control and verapamil-treated groups. Hence, there was
no evidence for a verapamil-mediated decrease in minimal
flow requirements for tissue survival in our preparations.
Implications. Verapamil does not appear to augment
collateral blood flow to myocardium jeopardized by isch-
emia, nor does it demonstrate infarct-sparing action that is
not mediated by flow in a closed chest dog model. Caution
must be exercised when extrapolating data from experi-
mental animals with a single acute occlusion to patients with
long-standing atherosclerotic disease that frequently affects
many vessels. Maturation of collateral vessels over pro-
longed periods, compromise of collateral flow by disease
in feeder arteries or prior exposure of myocardium to tran-
sient ischemia may substantially alter patient responses to
verapamil. Moreover, there are many well established
mechanisms by which verapamil may be beneficial during
coronary occlusive disease. However, the mechanisms ex-
plored iIi this study should not be included as modes of
verapamil-mediated benefit without further experimental
substantiation.
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